PHARMACOKINETICS OF 2-METHOXYETHANOL AND 2-METHOXYACETIC ACID IN THE PREGNANT MOUSE - A PHYSIOLOGICALLY-BASED MATHEMATICAL-MODEL

被引:32
作者
CLARKE, DO [1 ]
ELSWICK, BA [1 ]
WELSCH, F [1 ]
CONOLLY, RB [1 ]
机构
[1] CHEM IND INST TOXICOL,POB 12137,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1006/taap.1993.1151
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A physiologically based pharmacokinetic (PBPK) model was created to describe the disposition of 2-methoxyethanol (2-ME) and its teratogenic metabolite, 2-methoxyacetic acid (2-MAA), in the pregnant CD-1 mouse. The model’s foundation is a mathematical description of the physiological changes that occur during gestation (O’Flaherty et al., Toxicol. Appl. Pharmacol. 112, 245-256, 1992). The PBPK model was developed and validated with data collected on Gestational Day (GD) 11. Absorption, distribution, and oxidation of 2-ME to 2-MAA and ethylene glycol (EG) were stimulated. Flow-limited disposition of 2-ME in maternal tissues was described using in vitro-determined tissue partition coefficients (PCs). The maximum velocity (V(max)) of 2-ME oxidation to 2-MAA was calculated from literature-based in vitro data. V(max) for EG formation, and Michaelis constants for 2-MAA and EG pathways, were estimated from optimized simulations of plasma 2-ME and metabolic levels obtained after intravenous injection of 5-600 mg 2-ME·kg-1. 2-MAA disposition and elimination in the dam were described by a nonphysiological one-compartment model, which was linked to the 2-ME model, based on the volume of distribution (0.510 liters·kg-1) and overall elimination rate constant (0.124 hr-1) calculated friom iv 2-MAA plasma concentration-time courses. Transfer of 2-MAA between the placenta and conceptus was described as a diffusion-limited process to more accurately simulated the higher concentrations of 2-MAA determined in embryonic compartments compared with maternal plasma levels. Subsequent 2-MAA disposition within the embryo proper and surrounding fluid of the GD 11 conceptus was adequately described using embryo/blood (0.94) and extraembryonic fluid/blood (1.33) PCs. Extension of the PBPK model to oral and subcutaneous 2-ME administration required optimization of first-oder absorption rates; model simulations agreed closely with measured 2-ME/2-MAA levels. With refinements and further validation, the PBPK model of 2-ME/2-MAA disposition should prove helpful for extrapolation throughout gestation and between species. © 1994 Academic Press. All rights reserved.
引用
收藏
页码:239 / 252
页数:14
相关论文
共 62 条
[1]   PHYSIOLOGICAL MODELING OF ORGANIC-COMPOUNDS [J].
ANDERSEN, ME .
ANNALS OF OCCUPATIONAL HYGIENE, 1991, 35 (03) :309-321
[2]  
BEATON GH, 1954, J NUTR, V54, P291
[3]   THE TERATOGENICITY OF METHOXYACETIC ACID IN THE RAT [J].
BROWN, NA ;
HOLT, D ;
WEBB, M .
TOXICOLOGY LETTERS, 1984, 22 (01) :93-100
[4]  
BROWN NA, 1987, PHARMACOKINETICS TER, V2, P153
[5]   BLOOD-FLOW DURING PREGNANCY IN THE RAT .2. DYNAMICS OF AND LITTER VARIABILITY IN UTERINE FLOW [J].
BUELKESAM, J ;
HOLSON, JF ;
NELSON, CJ .
TERATOLOGY, 1982, 26 (03) :279-288
[6]   BLOOD-FLOW DURING PREGNANCY IN THE RAT .1. FLOW PATTERNS TO MATERNAL ORGANS [J].
BUELKESAM, J ;
NELSON, CJ ;
BYRD, RA ;
HOLSON, JF .
TERATOLOGY, 1982, 26 (03) :269-277
[7]   DIMETHOXYETHYLPHTHALATE METABOLISM - TERATOGENICITY OF THE DIESTER AND ITS METABOLITES IN THE PREGNANT RAT [J].
CAMPBELL, J ;
HOLT, D ;
WEBB, M .
JOURNAL OF APPLIED TOXICOLOGY, 1984, 4 (01) :35-41
[8]   PROTECTION AGAINST 2-METHOXYETHANOL-INDUCED TERATOGENESIS BY SERINE ENANTIOMERS - STUDIES OF POTENTIAL ALTERATION OF 2-METHOXYETHANOL PHARMACOKINETICS [J].
CLARKE, DO ;
MEBUS, CA ;
MILLER, FJ ;
WELSCH, F .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 110 (03) :514-526
[9]   2-METHOXYACETIC ACID DOSIMETRY TERATOGENICITY RELATIONSHIPS IN CD-1 MICE EXPOSED TO 2-METHOXYETHANOL [J].
CLARKE, DO ;
DUIGNAN, JM ;
WELSCH, F .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1992, 114 (01) :77-87
[10]  
CLARKE DO, 1992, TOXICOLOGIST, V12, P101